NAP
USNA icon

New Amsterdam Partners’s Usana Health Sciences USNA Stock Holding History

New Amsterdam Partners’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-220,160
Closed -$13.4M – 140
2016
Q1 		$13.4M Sell
220,160
-26,366
-11% -$1.55M 1.4% 35
2015
Q4 		$15.7M Buy
+246,526
New +$16M 1.63% 27

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New Amsterdam Partners's USNA Position: Q2 2016 in Review

New Amsterdam Partners sold out of Usana Health Sciences (USNA) in Q2 2016, closing a stake of 220,160 shares — an estimated $13.4M sold.

New Amsterdam Partners first reported a position in USNA in Q4 2015 and held it in 2 quarters. The position peaked at $15.7M in Q4 2015. 142 funds tracked by Wall St. Rank hold USNA as of Q2 2016.

  • New Amsterdam Partners reported no remaining Usana Health Sciences position as of Q2 2016 after selling out during the quarter.
  • New Amsterdam Partners sold 220,160 Usana Health Sciences shares in Q2 2016, an estimated $13.4M.
  • New Amsterdam Partners first reported a position in Usana Health Sciences in Q4 2015 and held it in 2 quarters.
  • New Amsterdam Partners's Usana Health Sciences position peaked at $15.7M in Q4 2015.
  • 142 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2016.

Based on New Amsterdam Partners's 13F filing for Q2 2016, filed 1 Aug 2016.